23 results
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Asthma Medications ... Mechanism of Action #Asthma ... Medications #Drugs #Pulmonary ... Pharmacology #Management #Treatment
Rapidly Growing Mycobacterial Infections

 • Mycobacterium abscessus - Is the most pathogenic and the most likely
Infections • Mycobacterium ... likely to cause pulmonary ... mortality • Mycobacterium ... infection • Mycobacterium ... infectiousdiseases #NTM
Algorithm for the Management of asthma exacerbations: emergency department and hospital-based treatment. 

#Asthma #Exacerbation #Algorithm #Management
Management of asthma ... hospital-based treatment ... #Asthma #Exacerbation ... Algorithm #Management #Pulmonary
Comparison of Chronic Asthma and COPD Management 2016

- Dr. Eric Strong @DrEricStrong - Strong Medicine https://www.youtube.com/c/EricsMedicalLectures/

#Asthma
Comparison of Chronic Asthma ... EricsMedicalLectures/ #Asthma ... Comparison #Chronic #Treatment ... #Management #Pulmonary
Nontuberculous mycobacteria
Nontuberculous mycobacteria, also known as atypical mycobacteria, are all the other mycobacteria which can cause
which can cause pulmonary ... with atypical mycobacterium ... #Mycobacteria #NTM
Severe Asthma Exacerbation
Signs of a Severe Asthma Exacerbation:
 • Vitals: ↑HR ↑RR ↓SpO2
 • High work
Severe Asthma Exacerbation ... Signs of a Severe Asthma ... of baseline Treatments ... #CriticalCare #pulmonary ... mechanical #management #treatment
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Initiative for Asthma ... (GINA) treatment ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #StepUp #Treatment
Nontuberculous Mycobacteria (NTM) Infections 

Mycobacterial species other than those belonging to the Mycobacterium tuberculosis complex and
belonging to the Mycobacterium ... Illnesses: • Pulmonary ... Classification grp IV): Pulmonary ... complicate MAC pulmonary ... Pulmonary Disease
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
africanum • Mycobacterium ... mycobacterial infection (NTM ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
africanum • Mycobacterium ... mycobacterial infection (NTM ... Tuberculosis Treatment ... Initiating Treatment ... Diagnosis #Management #Treatment